Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

Zeglis BM, Lewis JS.

Dalton Trans. 2011 Jun 21;40(23):6168-95. doi: 10.1039/c0dt01595d. Epub 2011 Mar 25.

2.

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

Shokeen M, Anderson CJ.

Acc Chem Res. 2009 Jul 21;42(7):832-41. doi: 10.1021/ar800255q.

3.

Radiometals: towards a new success story in nuclear imaging?

Brasse D, Nonat A.

Dalton Trans. 2015 Mar 21;44(11):4845-58. doi: 10.1039/c4dt02911a. Review.

PMID:
25437643
4.

Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.

Notni J, Šimeček J, Wester HJ.

ChemMedChem. 2014 Jun;9(6):1107-15. doi: 10.1002/cmdc.201400055. Epub 2014 Apr 3. Review. Erratum in: ChemMedChem. 2014 Dec;9(12):2614.

PMID:
24700633
5.

Matching chelators to radiometals for radiopharmaceuticals.

Price EW, Orvig C.

Chem Soc Rev. 2014 Jan 7;43(1):260-90. doi: 10.1039/c3cs60304k. Epub 2013 Oct 30. Review.

PMID:
24173525
6.

Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).

Deri MA, Ponnala S, Zeglis BM, Pohl G, Dannenberg JJ, Lewis JS, Francesconi LC.

J Med Chem. 2014 Jun 12;57(11):4849-60. doi: 10.1021/jm500389b. Epub 2014 May 19.

7.

Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.

Pandya DN, Pailloux S, Tatum D, Magda D, Wadas TJ.

Chem Commun (Camb). 2015 Feb 11;51(12):2301-3. doi: 10.1039/c4cc09256b.

8.

Bifunctional chelates for metal nuclides.

Brechbiel MW.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):166-73. Epub 2007 Nov 28. Review.

9.

Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies.

Rousseau J, Zhang Z, Dias GM, Zhang C, Colpo N, Bénard F, Lin KS.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):708-712. doi: 10.1016/j.bmcl.2017.01.052. Epub 2017 Jan 18.

PMID:
28131709
10.

Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Bhattacharyya S, Dixit M.

Dalton Trans. 2011 Jun 21;40(23):6112-28. doi: 10.1039/c1dt10379b. Epub 2011 May 3.

11.

The development of copper radiopharmaceuticals for imaging and therapy.

Shokeen M, Wadas TJ.

Med Chem. 2011 Sep;7(5):413-29. Review.

PMID:
21711219
12.

Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-Octreotide (M = Nb, Fe, Ga, Zr).

Radchenko V, Busse S, Roesch F.

Nucl Med Biol. 2014 Oct;41(9):721-7. doi: 10.1016/j.nucmedbio.2014.06.006. Epub 2014 Jul 4.

PMID:
25087170
13.

Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging.

Rockey WM, Huang L, Kloepping KC, Baumhover NJ, Giangrande PH, Schultz MK.

Bioorg Med Chem. 2011 Jul 1;19(13):4080-90. doi: 10.1016/j.bmc.2011.05.010. Epub 2011 May 14.

14.

Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.

Cai Z, Anderson CJ.

J Labelled Comp Radiopharm. 2014 Apr;57(4):224-30. doi: 10.1002/jlcr.3165. Epub 2013 Dec 18. Review.

15.

Radiometal complexes in molecular imaging and therapy.

Rey AM.

Curr Med Chem. 2010;17(31):3673-83. Review.

PMID:
20846111
16.

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ.

Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b.

PMID:
19489579
17.

(89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges.

Fischer G, Seibold U, Schirrmacher R, Wängler B, Wängler C.

Molecules. 2013 Jun 3;18(6):6469-90. doi: 10.3390/molecules18066469. Review.

18.

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Liu Z, Yan Y, Liu S, Wang F, Chen X.

Bioconjug Chem. 2009 May 20;20(5):1016-25. doi: 10.1021/bc9000245.

19.

Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals.

Burke BP, Clemente GS, Archibald SJ.

J Labelled Comp Radiopharm. 2014 Apr;57(4):239-43. doi: 10.1002/jlcr.3146. Epub 2014 Feb 4. Review.

PMID:
24497011
20.

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.

Rösch F, Baum RP.

Dalton Trans. 2011 Jun 21;40(23):6104-11. doi: 10.1039/c0dt01504k. Epub 2011 Mar 29.

PMID:
21445433

Supplemental Content

Support Center